NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球介入放射學產品市場□□(~ 2026 年):類型(支架、導管、IVC 過濾器、活檢針、栓塞裝置、配件)、治療(血管成形術、血管造影術、血栓溶解術、栓塞術)、應用(腫瘤)□按地區

Interventional Radiology Products Market by type (Stents, Catheters, IVC Filter, Biopsy Needles, Embolization Devices, Accessories), Procedure Type (Angioplasty, Angiography, Thrombolysis, Embolization), Applications (Oncology) - Global Forecast to 2026

出版商 MarketsandMarkets 商品編碼 1008361
出版日期 內容資訊 英文 214 Pages
訂單完成後即時交付
價格
全球介入放射學產品市場□□(~ 2026 年):類型(支架、導管、IVC 過濾器、活檢針、栓塞裝置、配件)、治療(血管成形術、血管造影術、血栓溶解術、栓塞術)、應用(腫瘤)□按地區 Interventional Radiology Products Market by type (Stents, Catheters, IVC Filter, Biopsy Needles, Embolization Devices, Accessories), Procedure Type (Angioplasty, Angiography, Thrombolysis, Embolization), Applications (Oncology) - Global Forecast to 2026
出版日期: 2021年05月25日內容資訊: 英文 214 Pages
簡介

在預測期內,全球介入放射學產品市場□□將以 6.6% 的複合年增長率增長,從 2021 年的 102 億美元增長到 2026 年的 141 億美元。據預測。

慢性病患病率上升、老年人口增加、微創手術需求增加以及有利的報銷方案等因素正在推動市場增長。另一方面,先進治療成本高、交通不便等問題可能會在一定程度上抑制市場的進一步增長。

通過

類型,支架部門預計在預測期內顯示出最大的規模和最大的複合年增長率。心臟病和癌症發病率的增加以及全球血管成形術的增加預計將推動該行業的增長。此外,按治療類別,血管造影部門預計將在同一時期顯示出最大的規模和最大的複合年增長率。對微創手術需求的增加、老年人口的增加以及心血管疾病發病率的增加等因素正在推動該行業的增長。

本報告探討了介入放射學產品的全球市場、市場定義和概述、價值鏈、分析新型冠狀病毒感染 (COVID-19) 和其他市場影響因素、方法。它總結了監管環境、技術分析/專利、市場規模轉變/預測、按類型/處理/使用/地區/主要國家、競爭環境、主要公司簡介等細分。

第 1 章介紹

第二章調查方法

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章市場概覽

  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 挑戰
  • 監管狀態
  • COVID-19 的影響
  • 技術分析
  • 價格分析
  • 貿易分析
  • 專利分析
  • 價值鏈分析
  • 供應鏈分析
  • 生態系統分析
  • 波特五力分析
  • YCC 班次

第 6 章市場分析/預測:按類型

  • 支架
  • 導管
    • 診斷導管
    • 治療導管
  • 下腔靜脈濾器
  • 血流校正裝置
  • 血管成形術球囊
  • 取栓系統
  • 栓塞裝置
  • 活檢針
  • 配件
    • 對比劑
    • 導絲
    • 氣球充氣裝置
    • 其他
  • 其他

第 7 章市場分析/預測:按處理

  • 血管造影
  • 血管成形術
  • 活檢/引流
  • 栓塞
  • 溶栓
  • 椎體形成
  • 腎瘺構建
  • 其他

第 8 章市場分析/預測:按應用

  • 泌尿科/腎臟科
  • 腫瘤
  • 消化內科
  • 神經內科
  • 骨科
  • 其他

第 9 章市場分析/預測:按地區/主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 其他領域

第10章競爭形勢

  • 概述
  • 市場份額分析
  • 企業評估象限
  • 中小企業/初創企業:評估象限
  • 競爭場景
  • 企業產品足跡

第 11 章公司簡介

  • 主要公司
    • MEDTRONIC PLC
    • BOSTON SCIENTIFIC CORPORATION
    • BECTON, DICKINSON AND COMPANY
    • ABBOTT
    • CARDINAL HEALTH
    • B. BRAUN MELSUNGEN AG
    • STRYKER
    • TERUMO MEDICAL CORPORATION
    • COOK MEDICAL
    • BIOSENSORS INTERNATIONAL GROUP, LTD.
    • TELEFLEX INCORPORATED
    • IVASCULAR S.L.U.
    • PENUMBRA, INC.
    • BIOTRONIK SE & CO. KG
    • ENDOCOR GMBH
    • MERIL LIFE SCIENCES PVT. LTD.
  • 其它有力企業
    • PALEX MEDICAL SA
    • URESIL, LLC
    • ALVIMEDICA
    • CARDIONOVUM GMBH
    • SMT
    • MEDINOL LTD.
    • COMED B.V.
    • SCITECH
    • BALTON SP. Z O.O.
    • RONTIS CORPORATION

第12章 附錄

目錄
Product Code: MD 4894

The global interventional radiology products market is projected to reach USD 14.1 billion by 2026 from USD 10.2 billion in 2021, at a CAGR of 6.6% during the forecast period. The growth in this market can be attributed to the rising prevalence of chronic diseases, growing geriatric population, increasing demand for minimally invasive procedures, and favorable reimbursement scenario for interventional radiology procedures. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, high cost and inaccessibility of advanced therapeutics may restrict market growth to a certain extent. The interventional radiology products market is segmented based on type, procedure, application, and region.

"Stentssegmentis expected to dominate the market during the forecast period and is also expected to grow at the highest CAGR during the forecast period."

Based on type, the interventional radiology products market is segmented into catheters, stents, inferior vena cava (IVC) filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, accessories (contrast media, guidewires, balloon inflation devices, and other accessories), and other interventional radiology products (bone cements, nephrostomy tubes, and gastrostomy tubes). Stents account for the largest share of the interventional radiology products market. The large share of this segment can be attributed to the increasing incidence of cardiac diseases and cancer and the growing number of angioplasty procedures performed globally.

"Angiographysegment to dominate the market during the forecast period."

Based on procedure, interventional radiology products can be segmented into angioplasty, angiography, embolization, thrombolysis, biopsy & drainage, vertebroplasty, nephrostomy, and other procedures (biliary drainage, fallopian tube recanalization, cholecystectomy, and radiofrequency ablation). Angiography account for the largest share of the interventional radiology products market and are expected to grow at the highest CAGR. The large share of this segment can be attributed to the increasing demand for minimally invasive procedures, the rising geriatric population, and the increasing incidence of CVD.

"Cardiology segment holds highest market share during the forecast period and is also expected to grow at the highest CAGR during the forecast period."

Based on applications, interventional radiology products can be segmented into cardiology, urology & nephrology, oncology, gastroenterology, neurology, orthopedics, and other applications (pulmonary and gynecology). Cardiology account for the largest share of the interventional radiology products market and are expected to grow at the highest CAGR. The large share of this segment can be attributed to the rising geriatric population and the increasing prevalence of CVD across the globe.

"North America will dominate the market during the forecast period."

The global interventional radiology products market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, Italy, and the Rest of Europe), Asia Pacific (Japan, China, India, and the Rest of Asia Pacific), and the Rest of the World. In 2020, North America dominated the global interventional radiology products market, followed by Europe. The large share of the North American market can be attributed to the high prevalence of chronic diseases, growing geriatric population, increasing adoption of minimally invasive procedures, and the presence of key players in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type -Tier 1: 70%, and Tier 2: 30%
  • By Designation - C-level:33%, D-level:40%, and Others:27%
  • By Region - North America:36%, Europe:28%, Asia Pacific:19%, and Rest of the World: 17%

List of Companies Profiled in the Report

  • Medtronic (Ireland)
  • Boston Scientific Corporation (US)
  • Becton, Dickinson and Company (US)
  • Abbott (US)
  • Cardinal Health (US)
  • B. Braun Melsungen AG (Germany)
  • Stryker (US)
  • Terumo Medical Corporation (Japan)
  • Cook Medical (US)
  • Biosensors International Group, Ltd. (Singapore)
  • Teleflex Incorporated (US)
  • iVascular S.L.U. (Spain)
  • Penumbra, Inc. (US)
  • BIOTRONIK SE & Co. KG (Germany)
  • ENDOCOR GmbH (Germany)
  • Meril Life Sciences Pvt. Ltd. (India)
  • Palex Medical (Spain)
  • UreSil, LLC (US)
  • Alvimedica (Turkey)
  • Cardionovum GmbH (Germany)
  • SMT (India)
  • Medinol Ltd. (Israel)
  • Comed B.V. (Netherlands)
  • SCITECH (Brazil)
  • Balton Sp. z o.o. (Poland)
  • Rontis (Switzerland)

Research Coverage:

This report provides a detailed picture of the global interventional radiology proceduresmarket. It aims at estimating the size and future growth potential of the market across different segments, such astype, procedure, applicationand region. The report also analyzes factors (such as drivers, restraints,opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total interventional radiology procedures market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on interventional radiology procedures offered by the top 26 players in the interventional radiology procedures market. The report analyses the interventional radiology proceduresmarket by product, type, technology, materialand region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various interventional radiology proceduresacross key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the interventional radiology proceduresmarket.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the interventional radiology proceduresmarket.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • FIGURE 1 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.1 GROWTH FORECAST
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 7 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 ASSUMPTIONS FOR THE STUDY
  • 2.5 COVID-19 ECONOMIC ASSESSMENT
  • 2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY

    • FIGURE 11 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET OVERVIEW
    • FIGURE 15 INCREASING INCIDENCE OF CHRONIC DISORDERS TO DRIVE MARKET GROWTH
  • 4.2 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE (2021-2026)
    • FIGURE 16 STENTS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • 4.3 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE AND COUNTRY (2020)
    • FIGURE 17 THE US DOMINATED THE NORTH AMERICAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET IN 2020
  • 4.4 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 INDIA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of chronic diseases
      • 5.2.1.2 Growing geriatric population
      • 5.2.1.3 Increasing demand for minimally invasive procedures
      • 5.2.1.4 Favorable reimbursement scenario for interventional radiology procedures
    • TABLE 1 REIMBURSEMENT FOR INTERVENTIONAL RADIOLOGY PROCEDURES IN THE US
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Availability of effective conventional first-level treatments
      • 5.2.2.2 High cost and inaccessibility of advanced therapeutics
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Entry barriers for new players
      • 5.2.4.2 Product failures and recalls
  • 5.3 REGULATORY LANDSCAPE
  • 5.4 COVID-19 IMPACT ON THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET
  • 5.5 TECHNOLOGY ANALYSIS
  • 5.6 PRICING ANALYSIS
    • TABLE 2 PRICES OF INTERVENTIONAL RADIOLOGY PRODUCTS
  • 5.7 TRADE ANALYSIS
    • TABLE 3 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 4 EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 5 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 6 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016-2020 (USD MILLION)
  • 5.8 PATENT ANALYSIS
  • 5.9 VALUE CHAIN ANALYSIS
    • FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
  • 5.10 SUPPLY CHAIN ANALYSIS
    • FIGURE 21 DIRECT DISTRIBUTION: A STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.11 ECOSYSTEM ANALYSIS
    • 5.11.1 ROLE IN THE ECOSYSTEM
    • TABLE 7 ROLE IN THE ECOSYSTEM
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 8 PORTER'S FIVE FORCES
    • 5.12.1 DEGREE OF COMPETITION
    • 5.12.2 BARGAINING POWER OF SUPPLIERS
    • 5.12.3 BARGAINING POWER OF BUYERS
    • 5.12.4 THREAT OF SUBSTITUTES
    • 5.12.5 THREAT OF NEW ENTRANTS
  • 5.13 YCC SHIFT

6 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 9 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 6.2 STENTS
    • 6.2.1 INCREASING ADOPTION OF DRUG-ELUTING STENTS AND BIOABSORBABLE STENTS-A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 10 INTERVENTIONAL RADIOLOGY STENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 CATHETERS
    • TABLE 11 INTERVENTIONAL RADIOLOGY CATHETERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 12 INTERVENTIONAL RADIOLOGY CATHETERS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.1 DIAGNOSTIC CATHETERS
      • 6.3.1.1 Diagnostic catheters held the largest share of the interventional radiology catheters market
    • TABLE 13 INTERVENTIONAL RADIOLOGY DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.2 THERAPEUTIC CATHETERS
      • 6.3.2.1 Increasing adoption of minimally invasive therapeutic procedures to drive market growth
    • TABLE 14 INTERVENTIONAL RADIOLOGY THERAPEUTIC CATHETERS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.4 INFERIOR VENA CAVA FILTERS
    • 6.4.1 INCREASING PREVALENCE OF PULMONARY EMBOLISM TO DRIVE MARKET GROWTH
    • TABLE 15 INTERVENTIONAL RADIOLOGY INFERIOR VENA CAVA FILTERS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.5 HEMODYNAMIC FLOW ALTERATION DEVICES
    • 6.5.1 RISING NUMBER OF REGULATORY APPROVALS AND TECHNOLOGICAL ADVANCEMENTS TO FAVOR MARKET GROWTH
    • TABLE 16 INTERVENTIONAL RADIOLOGY HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.6 ANGIOPLASTY BALLOONS
    • 6.6.1 RISING NUMBER OF REGULATORY APPROVALS FOR ANGIOPLASTY BALLOONS TO SUPPORT MARKET GROWTH
    • TABLE 17 INTERVENTIONAL RADIOLOGY ANGIOPLASTY BALLOONS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.7 THROMBECTOMY SYSTEMS
    • 6.7.1 INCREASING NUMBER OF PRODUCT INNOVATIONS AND APPROVALS TO AID MARKET GROWTH
    • TABLE 18 INTERVENTIONAL RADIOLOGY THROMBECTOMY SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.8 EMBOLIZATION DEVICES
    • 6.8.1 INCREASING INCIDENCE OF AORTIC ANEURYSMS IS A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 19 INTERVENTIONAL RADIOLOGY EMBOLIZATION DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.9 BIOPSY NEEDLES
    • 6.9.1 RISING PREVALENCE OF CANCER TO DRIVE THE ADOPTION OF BIOPSY NEEDLE PROCEDURES
    • TABLE 20 INTERVENTIONAL RADIOLOGY BIOPSY NEEDLES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.10 ACCESSORIES
    • TABLE 21 INTERVENTIONAL RADIOLOGY ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 22 INTERVENTIONAL RADIOLOGY ACCESSORIES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.10.1 CONTRAST MEDIA
      • 6.10.1.1 Contrast media segment held the largest share of the interventional radiology accessories market
    • TABLE 23 INTERVENTIONAL RADIOLOGY CONTRAST MEDIA MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.10.2 GUIDEWIRES
      • 6.10.2.1 Rising number of surgical procedures to favor market growth
    • TABLE 24 INTERVENTIONAL RADIOLOGY GUIDEWIRES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.10.3 BALLOON INFLATION DEVICES
      • 6.10.3.1 Growth in the number of angioplasty procedures to drive the demand for balloon inflation devices
    • TABLE 25 INTERVENTIONAL RADIOLOGY BALLOON INFLATION DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.10.4 OTHER ACCESSORIES
    • TABLE 26 INTERVENTIONAL RADIOLOGY MARKET FOR OTHER ACCESSORIES, BY REGION, 2019-2026 (USD MILLION)
  • 6.11 OTHER INTERVENTIONAL RADIOLOGY PRODUCTS
    • TABLE 27 OTHER INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY REGION, 2019-2026 (USD MILLION)

7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE

  • 7.1 INTRODUCTION
    • TABLE 28 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
  • 7.2 ANGIOGRAPHY
    • 7.2.1 ANGIOGRAPHY IS THE LARGEST & FASTEST-GROWING SEGMENT OF THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET
    • TABLE 29 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR ANGIOGRAPHY, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 ANGIOPLASTY
    • 7.3.1 RISING PREVALENCE OF STROKE TO DRIVE MARKET GROWTH
    • TABLE 30 NUMBER OF TRANSLUMINAL CORONARY ANGIOPLASTY PROCEDURES PERFORMED, BY COUNTRY, 2015 VS. 2018
    • TABLE 31 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR ANGIOPLASTY, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 BIOPSY & DRAINAGE
    • 7.4.1 RISING PREVALENCE OF CANCER HAS INCREASED THE DEMAND FOR BIOPSY & DRAINAGE PROCEDURES
    • TABLE 32 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR BIOPSY & DRAINAGE, BY REGION, 2019-2026 (USD MILLION)
  • 7.5 EMBOLIZATION
    • 7.5.1 INCREASING DEMAND FOR EMBOLIZATION IN THE TREATMENT OF FIBROIDS TO DRIVE MARKET GROWTH
    • TABLE 33 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR EMBOLIZATION, BY REGION, 2019-2026 (USD MILLION)
  • 7.6 THROMBOLYSIS
    • 7.6.1 RISING PREVALENCE OF DVT TO DRIVE MARKET GROWTH
    • TABLE 34 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR THROMBOLYSIS, BY REGION, 2019-2026 (USD MILLION)
  • 7.7 VERTEBROPLASTY
    • 7.7.1 INCREASING CASES OF OSTEOPOROSIS TO DRIVE THE DEMAND FOR VERTEBROPLASTY PROCEDURES
    • TABLE 35 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR VERTEBROPLASTY, BY REGION, 2019-2026 (USD MILLION)
  • 7.8 NEPHROSTOMY
    • 7.8.1 INCREASING PREVALENCE OF KIDNEY DISEASES TO SUPPORT MARKET GROWTH
    • TABLE 36 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR NEPHROSTOMY, BY REGION, 2019-2026 (USD MILLION)
  • 7.9 OTHER PROCEDURES
    • TABLE 37 NUMBER OF CHOLECYSTECTOMY PROCEDURES PERFORMED, BY COUNTRY, 2015 VS. 2018
    • TABLE 38 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR OTHER PROCEDURES, BY REGION, 2019-2026 (USD MILLION)

8 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 39 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 8.2 CARDIOLOGY
    • 8.2.1 CARDIOLOGY IS THE LARGEST APPLICATION SEGMENT OF THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET
    • TABLE 40 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR CARDIOLOGY, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 UROLOGY & NEPHROLOGY
    • 8.3.1 INNOVATION AND DEVELOPMENT OF PRODUCTS LIKE DRAINAGE CATHETERS TO SUPPORT MARKET GROWTH
    • TABLE 41 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR UROLOGY & NEPHROLOGY, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 ONCOLOGY
    • 8.4.1 ONCOLOGY IS THE FASTEST-GROWING APPLICATION SEGMENT IN THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET
    • TABLE 42 INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
    • TABLE 43 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR ONCOLOGY, BY REGION, 2019-2026 (USD MILLION)
  • 8.5 GASTROENTEROLOGY
    • 8.5.1 HIGH INCIDENCE OF GASTROINTESTINAL DISORDERS TO DRIVE MARKET GROWTH
    • TABLE 44 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR GASTROENTEROLOGY, BY REGION, 2019-2026 (USD MILLION)
  • 8.6 NEUROLOGY
    • 8.6.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
    • TABLE 45 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR NEUROLOGY, BY REGION, 2019-2026 (USD MILLION)
  • 8.7 ORTHOPEDICS
    • 8.7.1 RISING GERIATRIC POPULATION TO AID THE GROWTH OF THIS MARKET
    • TABLE 46 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR ORTHOPEDICS, BY REGION, 2019-2026 (USD MILLION)
  • 8.8 OTHER APPLICATIONS
    • TABLE 47 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)

9 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 48 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 22 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SNAPSHOT
    • TABLE 49 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 50 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 51 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 52 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US dominates the North American interventional radiology products market
    • TABLE 53 US: KEY MACROINDICATORS
    • TABLE 54 US: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 55 US: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 56 US: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 High burden of target diseases to drive the market in Canada
    • TABLE 57 CANADA: KEY MACROINDICATORS
    • TABLE 58 CANADA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 59 CANADA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 60 CANADA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 61 NUMBER OF SURGICAL PROCEDURES PER 100,000 POPULATION, BY COUNTRY, 2018
    • TABLE 62 EUROPE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 63 EUROPE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 64 EUROPE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 65 EUROPE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany held the largest share of the European market in 2020
    • TABLE 66 GERMANY: KEY MACROINDICATORS
    • TABLE 67 GERMANY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 68 GERMANY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 69 GERMANY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Government insurance schemes to support market growth
    • TABLE 70 UK: KEY MACROINDICATORS
    • TABLE 71 UK: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 72 UK: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 73 UK: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Large number of interventional radiology procedures to propel market growth
    • TABLE 74 FRANCE: KEY MACROINDICATORS
    • TABLE 75 FRANCE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 76 FRANCE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 77 FRANCE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Rising geriatric population in the country to support the market growth
    • TABLE 78 ITALY: KEY MACROINDICATORS
    • TABLE 79 ITALY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 80 ITALY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 81 ITALY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 9.3.5 REST OF EUROPE (ROE)
    • TABLE 82 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
    • TABLE 83 ROE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 ROE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 85 ROE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 23 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SNAPSHOT
    • TABLE 86 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 87 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 89 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Japan accounted for the largest share of the APAC market in 2020
    • TABLE 90 JAPAN: KEY INDICATORS
    • TABLE 91 JAPAN: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 92 JAPAN: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 93 JAPAN: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 High tobacco consumption to favor market growth
    • TABLE 94 CHINA: ESTIMATED ANNUAL DES VOLUME AND NUMBER OF CLASS III HOSPITALS, BY CITY (2019)
    • TABLE 95 CHINA: KEY INDICATORS
    • TABLE 96 CHINA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 97 CHINA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 98 CHINA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Improving healthcare infrastructure and rising number of hospitals to support market growth in India
    • TABLE 99 INDIA: KEY INDICATORS
    • TABLE 100 INDIA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 101 INDIA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 102 INDIA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC (ROAPAC)
    • TABLE 103 ROAPAC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 ROAPAC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 105 ROAPAC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 9.5 REST OF THE WORLD (ROW)
    • TABLE 106 ROW: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 107 ROW: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019-2026 (USD MILLION)
    • TABLE 108 ROW: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 24 KEY DEVELOPMENTS IN THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, JANUARY 2018-APRIL 2021
  • 10.2 MARKET SHARE ANALYSIS
    • TABLE 109 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: DEGREE OF COMPETITION (2020)
  • 10.3 COMPANY EVALUATION QUADRANT
    • 10.3.1 STARS
    • 10.3.2 EMERGING LEADERS
    • 10.3.3 PERVASIVE PLAYERS
    • 10.3.4 PARTICIPANTS
    • FIGURE 25 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: COMPANY EVALUATION QUADRANT, 2020
  • 10.4 COMPANY EVALUATION QUADRANT FOR SME/START-UPS
    • 10.4.1 PROGRESSIVE COMPANIES
    • 10.4.2 STARTING BLOCKS
    • 10.4.3 RESPONSIVE COMPANIES
    • 10.4.4 DYNAMIC COMPANIES
    • FIGURE 26 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: COMPANY EVALUATION QUADRANT FOR SME & START-UPS, 2020
  • 10.5 COMPETITIVE SCENARIO
    • FIGURE 27 MARKET EVALUATION MATRIX, 2018-2021
    • 10.5.1 DEALS
    • TABLE 110 DEALS
    • 10.5.2 PRODUCT LAUNCHES
    • TABLE 111 PRODUCT LAUNCHES
    • 10.5.3 OTHER DEVELOPMENTS
    • TABLE 112 OTHER DEVELOPMENTS
  • 10.6 COMPANY PRODUCT FOOTPRINT
    • TABLE 113 COMPANY FOOTPRINT
    • FIGURE 28 COMPANY PRODUCT FOOTPRINT
    • FIGURE 29 COMPANY APPLICATION FOOTPRINT
    • TABLE 114 COMPANY GEOGRAPHICAL FOOTPRINT

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 11.1.1 MEDTRONIC PLC
    • TABLE 115 MEDTRONIC: BUSINESS OVERVIEW
    • FIGURE 30 MEDTRONIC: COMPANY SNAPSHOT (2020)
    • 11.1.2 BOSTON SCIENTIFIC CORPORATION
    • TABLE 116 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
    • FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.3 BECTON, DICKINSON AND COMPANY
    • TABLE 117 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 32 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
    • 11.1.4 ABBOTT
    • TABLE 118 ABBOTT: BUSINESS OVERVIEW
    • FIGURE 33 ABBOTT: COMPANY SNAPSHOT (2020)
    • 11.1.5 CARDINAL HEALTH
    • TABLE 119 CARDINAL HEALTH: BUSINESS OVERVIEW
    • FIGURE 34 CARDINAL HEALTH: COMPANY SNAPSHOT (2020)
    • 11.1.6 B. BRAUN MELSUNGEN AG
    • TABLE 120 B. BRAUN MELSUNGEN: BUSINESS OVERVIEW
    • FIGURE 35 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)
    • TABLE 121 EXCHANGE RATES USED FOR THE CONVERSION OF EUR TO USD
    • 11.1.7 STRYKER
    • TABLE 122 STRYKER: BUSINESS OVERVIEW
    • FIGURE 36 STRYKER: COMPANY SNAPSHOT (2020)
    • 11.1.8 TERUMO MEDICAL CORPORATION
    • TABLE 123 TERUMO MEDICAL CORPORATION: BUSINESS OVERVIEW
    • FIGURE 37 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2019)
    • TABLE 124 EXCHANGE RATES USED FOR THE CONVERSION OF JPY TO USD
    • 11.1.9 COOK MEDICAL
    • TABLE 125 COOK MEDICAL: BUSINESS OVERVIEW
    • 11.1.10 BIOSENSORS INTERNATIONAL GROUP, LTD.
    • TABLE 126 BIOSENSORS INTERNATIONAL GROUP, LTD.: BUSINESS OVERVIEW
    • 11.1.11 TELEFLEX INCORPORATED
    • TABLE 127 TELEFLEX INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 38 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020)
    • 11.1.12 IVASCULAR S.L.U.
    • TABLE 128 IVASCULAR S.L.U.: BUSINESS OVERVIEW
    • 11.1.13 PENUMBRA, INC.
    • TABLE 129 PENUMBRA, INC.: BUSINESS OVERVIEW
    • FIGURE 39 PENUMBRA, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.14 BIOTRONIK SE & CO. KG
    • TABLE 130 BIOTRONIK SE & CO. KG: BUSINESS OVERVIEW
    • 11.1.15 ENDOCOR GMBH
    • TABLE 131 ENDOCOR GMBH: BUSINESS OVERVIEW
    • 11.1.16 MERIL LIFE SCIENCES PVT. LTD.
    • TABLE 132 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 PALEX MEDICAL SA
    • 11.2.2 URESIL, LLC
    • 11.2.3 ALVIMEDICA
    • 11.2.4 CARDIONOVUM GMBH
    • 11.2.5 SMT
    • 11.2.6 MEDINOL LTD.
    • 11.2.7 COMED B.V.
    • 11.2.8 SCITECH
    • 11.2.9 BALTON SP. Z O.O.
    • 11.2.10 RONTIS CORPORATION
  • *Business Overview, Products/Services/Solutions Offered, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS